Overview
Isolated cloverleaf skull syndrome, also known as isolated Kleeblattschädel anomaly, is an extremely rare craniofacial condition characterized by a trilobed (cloverleaf-shaped) skull resulting from premature fusion (craniosynostosis) of multiple cranial sutures. The distinctive skull shape occurs because the brain is forced to expand through the remaining open sutures and fontanelles, creating bulging protrusions in the temporal and frontal regions that give the head its characteristic three-lobed appearance. This entry is now considered obsolete in Orphanet, as isolated cloverleaf skull is generally reclassified under broader craniosynostosis syndromes or recognized as a severe phenotypic manifestation of other conditions such as thanatophoric dysplasia type II, Crouzon syndrome, Pfeiffer syndrome, or other skeletal dysplasias rather than a distinct standalone entity. The condition primarily affects the skeletal system, particularly the craniofacial bones, and secondarily impacts the central nervous system. Key clinical features include severe craniosynostosis, hydrocephalus, proptosis (bulging eyes) due to shallow orbits, and potential brain compression leading to increased intracranial pressure. Affected individuals may experience respiratory difficulties, hearing loss, and developmental delays depending on the severity and underlying cause. The facial features are often markedly abnormal with midface hypoplasia. Management is primarily surgical and supportive. Neurosurgical intervention is typically required early in life to relieve intracranial pressure and may include cranial vault remodeling, shunt placement for hydrocephalus, and staged craniofacial reconstruction. Prognosis varies significantly depending on the underlying etiology and severity of associated anomalies. When cloverleaf skull occurs in isolation without an underlying lethal skeletal dysplasia, outcomes may be more favorable with aggressive surgical management, though significant morbidity remains common.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Isolated cloverleaf skull syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Isolated cloverleaf skull syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Isolated cloverleaf skull syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Isolated cloverleaf skull syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Isolated cloverleaf skull syndrome.
Start the conversation →Latest news about OBSOLETE: Isolated cloverleaf skull syndrome
No recent news articles for OBSOLETE: Isolated cloverleaf skull syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Isolated cloverleaf skull syndrome
What is OBSOLETE: Isolated cloverleaf skull syndrome?
Isolated cloverleaf skull syndrome, also known as isolated Kleeblattschädel anomaly, is an extremely rare craniofacial condition characterized by a trilobed (cloverleaf-shaped) skull resulting from premature fusion (craniosynostosis) of multiple cranial sutures. The distinctive skull shape occurs because the brain is forced to expand through the remaining open sutures and fontanelles, creating bulging protrusions in the temporal and frontal regions that give the head its characteristic three-lobed appearance. This entry is now considered obsolete in Orphanet, as isolated cloverleaf skull is ge
At what age does OBSOLETE: Isolated cloverleaf skull syndrome typically begin?
Typical onset of OBSOLETE: Isolated cloverleaf skull syndrome is neonatal. Age of onset can vary across affected individuals.